I faced this question more times then I can recall. I asked NIH to
clarify a year ago at one of the meetings. We must indeed submit close
out reports for each competitive segment - no doubt about it in my mind
any longer. I advise our PIs to submit for the progress report the same
text that they submit as progress report in the renewal application and
to make it very clear that the research project is still continuing.

Zoya

--
Zoya Hamilton, CRA
Sr. Associate Director, Research Administration
Office of the Vice Provost
Tufts University
Tel (617) 636-6709
Fax (617) 636-2917
http://researchadmin.tufts.edu/

Kate McCormick wrote:
> We recently had this experience as well. We are a subcontract on the
> award and the prime said that while a final progress report was not
> due, we still needed to send them our Final Invention Statement. I
> love it when they change policy and don't let anyone know.
>
> Kate
>
> At 11:05 AM 5/13/2010, Cindy Fuqua wrote:
>> Hi all,
>>
>> We recently received an automated closeout request from NIAID for the
>> standard items (Final Progress Report, Final Invention Statement,
>> Final FSR) for a grant that is currently renewed (Type 2 not
>> ARRA-funded; no lapse in funding). When I tried to explain that this
>> is in conflict with NIH closeout policy (“NIH closes out a grant as
>> soon as possible after expiration _if the grant will not be extended
>> or if continued funding is not provided_.”) I was told that NIAID
>> requires their staff to close out each competing segment of a grant.
>> I was finally told that we do not have to submit the Final Progress
>> Report at this time, although it still appears as outstanding in
>> Commons, but we must submit the Final Invention Statement. I would be
>> interested to know if anybody else has had a similar experience.
>>
>> Many thanks!
>>
>> Cindy Fuqua
>> Manager, Administrative Post-Award
>> Sponsored Research and Program Development
>> The Rockefeller University
>> 1230 York Avenue, Box 82
>> New York, NY 10065-6399
>> p: 212-327-8055
>> f: 212-327-8400
>> e: xxxxxx@rockefeller.edu
>>
>> ======================================================================
>> Instructions on how to use the RESADM-L Mailing List, including
>> subscription information and a web-searchable archive, are available
>> via our web site at http://www.hrinet.org <http://www.hrinet.org/>
>> (click on "Listserv Lists")
>> ======================================================================
>
>
>
> Kate McCormick, CRA
> Assistant Director of Finance & Administration
> Department of Pathology
> Harvard Medical School
> xxxxxx@hms.harvard.edu
> (617) 432-1982
> (617) 432-1207 (fax)
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================